ANGIODYNAMICS INC (ANGO)
US03475V1017 - Common Stock
ANGO gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 188 industry peers in the Health Care Equipment & Supplies industry. ANGO scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. ANGO is valued expensive and it does not seem to be growing.
1. Profitability
1.1 Basic Checks
ANGO had negative earnings in the past year.
ANGO had a negative operating cash flow in the past year.
In the past 5 years ANGO always reported negative net income.
In multiple years ANGO reported negative operating cash flow during the last 5 years.
1.2 Ratios
Looking at the Return On Assets, with a value of -82.77%, ANGO is doing worse than 80.75% of the companies in the same industry.
ANGO's Return On Equity of -123.63% is on the low side compared to the rest of the industry. ANGO is outperformed by 71.66% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -82.77% | ||
| ROE | -123.63% | ||
| ROIC | N/A |
ROA(3y)-24.22%
ROA(5y)-21.27%
ROE(3y)-36.59%
ROE(5y)-30.72%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
ANGO's Gross Margin of 51.71% is in line compared to the rest of the industry. ANGO outperforms 43.85% of its industry peers.
ANGO's Gross Margin has declined in the last couple of years.
ANGO does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 51.71% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.88%
GM growth 5Y-2.46%
2. Health
2.1 Basic Checks
ANGO does not have a ROIC to compare to the WACC, probably because it is not profitable.
ANGO has more shares outstanding than it did 1 year ago.
Compared to 5 years ago, ANGO has more shares outstanding
ANGO has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
2.2 Solvency
ANGO has an Altman-Z score of 0.75. This is a bad value and indicates that ANGO is not financially healthy and even has some risk of bankruptcy.
ANGO has a Altman-Z score (0.75) which is comparable to the rest of the industry.
ANGO has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | N/A | ||
| Altman-Z | 0.75 |
ROIC/WACCN/A
WACC8.87%
2.3 Liquidity
ANGO has a Current Ratio of 2.25. This indicates that ANGO is financially healthy and has no problem in meeting its short term obligations.
The Current ratio of ANGO (2.25) is worse than 64.71% of its industry peers.
A Quick Ratio of 1.41 indicates that ANGO should not have too much problems paying its short term obligations.
The Quick ratio of ANGO (1.41) is worse than 66.84% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 2.25 | ||
| Quick Ratio | 1.41 |
3. Growth
3.1 Past
The earnings per share for ANGO have decreased strongly by -216.67% in the last year.
Looking at the last year, ANGO shows a very negative growth in Revenue. The Revenue has decreased by -12.85% in the last year.
ANGO shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 2.35% yearly.
EPS 1Y (TTM)-216.67%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%8.33%
Revenue 1Y (TTM)-12.85%
Revenue growth 3Y1.46%
Revenue growth 5Y2.35%
Sales Q2Q%-14.22%
3.2 Future
Based on estimates for the next years, ANGO will show a very strong growth in Earnings Per Share. The EPS will grow by 36.17% on average per year.
ANGO is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 7.31% yearly.
EPS Next Y-4.62%
EPS Next 2Y17.15%
EPS Next 3Y33.25%
EPS Next 5Y36.17%
Revenue Next Year-3.03%
Revenue Next 2Y2.19%
Revenue Next 3Y5.45%
Revenue Next 5Y7.31%
3.3 Evolution
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
ANGO reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for ANGO. No positive earnings are expected for the next year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A |
4.2 Price Multiples
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | N/A |
4.3 Compensation for Growth
ANGO's earnings are expected to grow with 33.25% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y17.15%
EPS Next 3Y33.25%
5. Dividend
5.1 Amount
No dividends for ANGO!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
ANGIODYNAMICS INC
NASDAQ:ANGO (11/4/2024, 8:00:00 PM)
After market: 6.74 0 (0%)6.74
+0.06 (+0.9%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap273.85M
Analysts
Price Target
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A | ||
| P/S | |||
| P/FCF | |||
| P/OCF | |||
| P/B | |||
| P/tB | |||
| EV/EBITDA |
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -82.77% | ||
| ROE | -123.63% | ||
| ROCE | |||
| ROIC | |||
| ROICexc | |||
| ROICexgc | |||
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 51.71% | ||
| FCFM |
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover1
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | |||
| Debt/EBITDA | |||
| Cap/Depr | |||
| Cap/Sales | |||
| Interest Coverage | |||
| Cash Conversion | |||
| Profit Quality | |||
| Current Ratio | 2.25 | ||
| Quick Ratio | 1.41 | ||
| Altman-Z |
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
High Growth Momentum
Growth
EPS 1Y (TTM)-216.67%
EPS 3YN/A
EPS 5Y
EPS Q2Q%
EPS Next Y-4.62%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)-12.85%
Revenue growth 3Y1.46%
Revenue growth 5Y
Sales Q2Q%
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y